ישראל - עברית - Ministry of Health

לה קרים סופ בעמ - הזנה לעור

ישראל - עברית - Ministry of Health

bioavenir ltd, israel - latanoprost; timolol as maleate - תמיסה לעין - timolol as maleate 5 mg / 1 ml; latanoprost 0.05 mg / 1 ml - timolol

ישראל - עברית - Ministry of Health

לין ננו טכנולוגיה בעמ - הענקת צבע אחיד לעור

ישראל - עברית - Ministry of Health

לין ננו טכנולוגיה בעמ - הענקת צבע אחיד לעור

ישראל - עברית - Ministry of Health

לין ננו טכנולוגיה בעמ - הענקת צבע אחיד לעור

ישראל - עברית - Ministry of Health

לין ננו טכנולוגיה בעמ - ניקוי השיער

ישראל - עברית - Ministry of Health

abic marketing ltd - ceftazidime as pentahydrate 2 g/vial - powder for solution for injection - ceftazidime - treatment of single or multiple infections caused by susceptible microorganisms.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - ceftazidime as pentahydrate - אבקה להכנת תמיסה לזריקה - ceftazidime as pentahydrate 1 g/vial - ceftazidime - ceftazidime - treatment of single or multiple infections caused by susceptible microorganisms.

ישראל - עברית - Ministry of Health

bioavenir ltd - gemcitabine 200 mg/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

ישראל - עברית - Ministry of Health

bioavenir ltd - gemcitabine 1000 mg/vial - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.